Minerva Neurosciences (NERV) Shareholder's Equity (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Minerva Neurosciences 215.11 Mn 215.11 Mn - -254.01 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -254.01 Mn
Dec 31, 2025 -140.75 Mn
Sep 30, 2025 -34.58 Mn
Jun 30, 2025 -32.11 Mn
Mar 31, 2025 -29.15 Mn
Dec 31, 2024 -25.69 Mn
Sep 30, 2024 -21.67 Mn
Jun 30, 2024 -44.49 Mn
Mar 31, 2024 -36.59 Mn
Dec 31, 2023 -28.46 Mn
Sep 30, 2023 -20.05 Mn
Jun 30, 2023 -12.51 Mn
Mar 31, 2023 -26.62 Mn
Dec 31, 2022 -20.02 Mn
Sep 30, 2022 -14.25 Mn
Jun 30, 2022 -8.38 Mn
Mar 31, 2022 -736,130.00
Dec 31, 2021 7.98 Mn
Sep 30, 2021 28.08 Mn
Jun 30, 2021 36.17 Mn
Mar 31, 2021 45.37 Mn
Dec 31, 2020 52.66 Mn
Sep 30, 2020 58.02 Mn
Jun 30, 2020 56.94 Mn
Mar 31, 2020 18.62 Mn
Dec 31, 2019 27.78 Mn
Sep 30, 2019 55.53 Mn
Jun 30, 2019 67.27 Mn
Mar 31, 2019 77.42 Mn
Dec 31, 2018 90.26 Mn
Sep 30, 2018 101.39 Mn
Jun 30, 2018 110.66 Mn
Mar 31, 2018 121.29 Mn
Dec 31, 2017 131.60 Mn
Sep 30, 2017 130.18 Mn
Jun 30, 2017 98.03 Mn
Mar 31, 2017 106.29 Mn
Dec 31, 2016 105.98 Mn
Sep 30, 2016 113.14 Mn
Jun 30, 2016 120.61 Mn
Mar 31, 2016 66.65 Mn
Dec 31, 2015 55.32 Mn
Sep 30, 2015 63.07 Mn
Jun 30, 2015 68.38 Mn
Mar 31, 2015 74.44 Mn
Dec 31, 2014 51.50 Mn
Sep 30, 2014 56.72 Mn
Jun 30, 2014 29.23 Mn
Dec 31, 2013 20.18 Mn